indomethacin has been researched along with Fetal Growth Restriction in 8 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "of indomethacin was associated with closure of PDA in 108 (77." | 5.35 | Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants. ( Lee, J; Yang, CZ, 2008) |
| "Indomethacin was used for median (IQR) 3 (2-5) days while ibuprofen was given for 3 (2-4) days, at a median of 8 and 10 days after birth, respectively; surgical treatment was used later at 33 (24-45) days after birth." | 1.72 | Management of patent ductus arteriosus in very preterm infants in England and Wales: a retrospective cohort study. ( Al-Turkait, A; Choonara, I; Ojha, S; Szatkowski, L, 2022) |
| "Pregnancy in patients with chronic renal failure occurs rarely but the incidence is increasing." | 1.37 | Successful management of a high-risk pregnancy with polyhydramnios, IUGR and recurrent pregnancy loss in a chronic renal failure patient: a case report. ( Baykal, C; Kaya, S; Takal, MK; Yakupoğlu, U, 2011) |
| "of indomethacin was associated with closure of PDA in 108 (77." | 1.35 | Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants. ( Lee, J; Yang, CZ, 2008) |
| "The chronic use of prostaglandin synthetase inhibitors is reported in a pregnant patient with severe juvenile rheumatoid arthritis." | 1.26 | Oligohydramnios and transient neonatal anuria: a possible association with the maternal use of prostaglandin synthetase inhibitors. ( Cantor, B; Nelson, RM; Stein, GH; Tyler, T, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Turkait, A | 1 |
| Szatkowski, L | 1 |
| Choonara, I | 1 |
| Ojha, S | 1 |
| Villamor, E | 1 |
| Borges-Luján, M | 1 |
| González-Luis, G | 1 |
| Shanahan, KH | 1 |
| Yu, X | 1 |
| Miller, LG | 1 |
| Freedman, SD | 1 |
| Martin, CR | 1 |
| Yang, CZ | 1 |
| Lee, J | 1 |
| Baykal, C | 1 |
| Kaya, S | 1 |
| Takal, MK | 1 |
| Yakupoğlu, U | 1 |
| Barreto, RR | 1 |
| Franco, Ede S | 1 |
| Brasileiro, CF | 1 |
| de Oliveira, AP | 1 |
| Dimech, GS | 1 |
| Malta, DJ | 1 |
| Cazuzu, JS | 1 |
| Leite, AC | 1 |
| da Silva, TG | 1 |
| Maia, MB | 1 |
| Cantor, B | 1 |
| Tyler, T | 1 |
| Nelson, RM | 1 |
| Stein, GH | 1 |
| Tsuruta, K | 1 |
| Mori, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Drug Utilization Patterns in Neonatal Units in the UK: a Retrospective Pharmaco-epidemiological Study[NCT03773289] | 642,729 participants (Actual) | Observational | 2018-04-20 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for indomethacin and Fetal Growth Restriction
| Article | Year |
|---|---|
Association of patent ductus arteriosus with fetal factors and endotypes of prematurity.
Topics: Ductus Arteriosus, Patent; Female; Fetal Growth Retardation; Humans; Ibuprofen; Indomethacin; Infant | 2023 |
7 other studies available for indomethacin and Fetal Growth Restriction
| Article | Year |
|---|---|
Management of patent ductus arteriosus in very preterm infants in England and Wales: a retrospective cohort study.
Topics: Ductus Arteriosus, Patent; Female; Fetal Growth Retardation; Humans; Ibuprofen; Indomethacin; Infant | 2022 |
Early Serum Gut Hormone Concentrations Associated With Time to Full Enteral Feedings in Preterm Infants.
Topics: Cardiovascular Agents; Ductus Arteriosus, Patent; Enteral Nutrition; Female; Fetal Growth Retardatio | 2018 |
Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants.
Topics: Birth Weight; Causality; Cohort Studies; Ductus Arteriosus, Patent; Female; Fetal Growth Retardation | 2008 |
Successful management of a high-risk pregnancy with polyhydramnios, IUGR and recurrent pregnancy loss in a chronic renal failure patient: a case report.
Topics: Abortion, Habitual; Adult; Amniotic Fluid; Betamethasone; Birth Weight; Female; Fetal Growth Retarda | 2011 |
Early undernutrition is associated with attenuated inflammatory response and alteration in pharmacological efficacy of indomethacin in rats.
Topics: Analysis of Variance; Animal Feed; Animals; Anti-Inflammatory Agents, Non-Steroidal; Birth Weight; C | 2012 |
Oligohydramnios and transient neonatal anuria: a possible association with the maternal use of prostaglandin synthetase inhibitors.
Topics: Adult; Anuria; Arthritis, Juvenile; Blood Urea Nitrogen; Creatinine; Cyclooxygenase Inhibitors; Fema | 1980 |
[Experimental intrauterine growth retardation with indomethacin].
Topics: Animals; Body Weight; Cyclooxygenase Inhibitors; Fasting; Female; Fetal Growth Retardation; Gestatio | 1986 |